XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities:    
Net income (loss) $ (800) $ 3,452
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 1,138 823
Amortization of internally developed software 2,806 1,501
Amortization of intangible assets 176 547
Stock-based compensation expense 11,402 8,714
Deferred income taxes (570) (2,141)
Other non-cash items 420 223
Changes in operating assets and liabilities:    
Accounts receivable (48) 1,664
Contract assets – commissions receivable 50,635 26,873
Prepaid expenses and other assets 4,225 (159)
Accounts payable (25,826) (16,279)
Accrued compensation and benefits 4,088 (11,104)
Accrued marketing expenses (6,712) (7,329)
Deferred revenue 570 113
Accrued expenses and other liabilities 1,305 2,009
Net cash provided by operating activities 42,809 8,907
Investing activities:    
Capitalized internal-use software and website development costs (3,242) (3,564)
Purchases of property and equipment and other assets (1,899) (2,508)
Purchases of marketable securities (7,771) (58,064)
Proceeds from redemption and maturities of marketable securities 23,409 0
Net cash provided by (used in) investing activities 10,497 (64,136)
Financing activities:    
Proceeds from issuance of common stock, net of issuance costs 0 228,024
Net proceeds from exercise of common stock options 285 1,091
Repurchase of shares to satisfy employee tax withholding obligations (5,037) (4,375)
Acquisition-related contingent payments 0 (8,751)
Principal payments in connection with leases (38) (58)
Net cash provided by (used in) financing activities (4,790) 215,931
Effect of exchange rate changes on cash, cash equivalents and restricted cash (25) (2)
Net increase in cash, cash equivalents and restricted cash 48,491 160,700
Cash, cash equivalents and restricted cash at beginning of period 47,113 26,820
Cash, cash equivalents and restricted cash at end of period $ 95,604 $ 187,520